Skip to main content

Table 1 Analytical performance data for the determination of the studied drugs by the proposed method.

From: Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma

Parameter

ROS

GLM

Linearity range (μg/mL)

0.10-25

0.125-12.5

Intercept (a)

-5.9 × 10-4

-1.7 × 10-3

Slope (b)

0.119

0.122

Correlation coefficient (r)

0.9999

0.9999

S.D. of residuals (S y/x )

6.90 × 10-3

2.68 × 10-3

S.D. of intercept (S a )

1.58 × 10-3

1.39 × 10-3

S.D. of slope (S b )

2.88 × 10-4

2.36 × 10-4

Percentage relative standard deviation, % RSD

0.80

0.92

Percentage relative error, % Error

0.28

0.35

Limit of detection, LOD (μg/mL)

0.04

0.04

Limit of quantitation, LOQ (μg/mL)

0.13

0.11